21 May 2009
Analysis of risk factors influencing acute graft rejection in allograft recipients
P Jurkowski, A Mikłaszewicz, M Cićkiewicz, P Orszulak, M Fiedor, Z Lewandowski, P FiedorAnn Transplant 2009; 14(1): 76-76 :: ID: 880480
Abstract
Background: Stability of graft function after allotransplantation is difficult to maintain. There are many factors that can worsen recipient's condition and may lead to acute graft rejection. The aim of this study was to evaluate the influence of various factors on the incidence of acute graft rejection episodes in patients after liver and kidney allotransplantation.
Material/Methods: 171 recipients after kidney and liver transplantation were
analyzed. Factors of interest included: immunosuppression patterns, existence of diabetes, received induction therapy, warm and cold ischemia time and acute rejection time. Next, the data of donors for the 171 patients was collected. All data was statistically analyzed.
Results: The number of kidney and liver recipients without acute graft rejection was the lowest for CsA and CellCept model compared to the highest for CsA and Aza model (p=0.0008). Tacrolimus causes the highest risk of induced diabetes after transplantation (p<0.001). The number of kidney and liver recipients with acute graft rejection was higher in patients who received graft from females comparing with the group who received grafts from males (p=0.0282). Every minute of warm ischemia time increases the risk of acute
graft rejection by 12.7%. The percentage of patients without AGR after 7 months with 2 common alleles, 1 common allele and 0 common alleles in HLA-DR was 100%, 55% and 30% respectively (p=0.0128).
Conclusions: The acute rejection time depends on many factors and how they affect graft stability was elucidated in this study.
Keywords: Immunosuppression, Kidney Transplantation, Liver Transplantation
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






